Alliance Pharma AIM Listing Canceled After £362M Takeover
Consumer healthcare company Alliance Pharma PLC said Thursday that it has canceled its share trading on London's junior AIM market following its £362 million ($481 million) takeover by a consortium that...To view the full article, register now.
Already a subscriber? Click here to view full article